EXPERIENCE OF CLINICAL USE OF RITUXIMAB IN PATIENT WITH SYSTEMIC JUVENILE ARTHRITIS (A CASE REPORT)

<em>The case of early onset and severe course of systemic juvenile rheumatoid arthritis refractory to classic immunosuppressive agents and blockers of tumor necrosis factor (TNF) is presented in this article. Successful clinical use of biological agent rituximab was described. extraarticular s...

Full description

Bibliographic Details
Main Authors: E.I. Alexeeva, E.L. Semikina, T.M. Bzarova, S.I. Valieva, R.V. Denisova, A.O. Lisitsin, E.Yu. Gudkova, S.S. Akulova, E.A. Kopyl'tsova
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2008-01-01
Series:Вопросы современной педиатрии
Online Access:http://vsp.spr-journal.ru:80/jour/article/view/1402
_version_ 1827848244524220416
author E.I. Alexeeva
E.L. Semikina
T.M. Bzarova
S.I. Valieva
R.V. Denisova
A.O. Lisitsin
E.Yu. Gudkova
S.S. Akulova
E.A. Kopyl'tsova
author_facet E.I. Alexeeva
E.L. Semikina
T.M. Bzarova
S.I. Valieva
R.V. Denisova
A.O. Lisitsin
E.Yu. Gudkova
S.S. Akulova
E.A. Kopyl'tsova
author_sort E.I. Alexeeva
collection DOAJ
description <em>The case of early onset and severe course of systemic juvenile rheumatoid arthritis refractory to classic immunosuppressive agents and blockers of tumor necrosis factor (TNF) is presented in this article. Successful clinical use of biological agent rituximab was described. extraarticular symptoms of disease were stopped by 6 week of treatment, and acute inflammatory alteration of articulations was reduced by 16 week, the range of motions was completely restored. This case report demonstrates high activity of rituximab. A clinical and laboratory remission of disease in patient with severe course of systemic juvenile rheumatoid arthritis continues for a 32 weeks.</em><br /><strong><em>Key words: children, juvenile rheumatoid arthritis, rituximab.</em></strong>
first_indexed 2024-03-12T09:44:10Z
format Article
id doaj.art-79d2b84f9d024ad49e00374e54896067
institution Directory Open Access Journal
issn 1682-5527
1682-5535
language English
last_indexed 2024-03-12T09:44:10Z
publishDate 2008-01-01
publisher "Paediatrician" Publishers LLC
record_format Article
series Вопросы современной педиатрии
spelling doaj.art-79d2b84f9d024ad49e00374e548960672023-09-02T13:00:52Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352008-01-017379851402EXPERIENCE OF CLINICAL USE OF RITUXIMAB IN PATIENT WITH SYSTEMIC JUVENILE ARTHRITIS (A CASE REPORT)E.I. Alexeeva0E.L. Semikina1T.M. Bzarova2S.I. Valieva3R.V. Denisova4A.O. Lisitsin5E.Yu. Gudkova6S.S. Akulova7E.A. Kopyl'tsova8Scientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowScientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow<em>The case of early onset and severe course of systemic juvenile rheumatoid arthritis refractory to classic immunosuppressive agents and blockers of tumor necrosis factor (TNF) is presented in this article. Successful clinical use of biological agent rituximab was described. extraarticular symptoms of disease were stopped by 6 week of treatment, and acute inflammatory alteration of articulations was reduced by 16 week, the range of motions was completely restored. This case report demonstrates high activity of rituximab. A clinical and laboratory remission of disease in patient with severe course of systemic juvenile rheumatoid arthritis continues for a 32 weeks.</em><br /><strong><em>Key words: children, juvenile rheumatoid arthritis, rituximab.</em></strong>http://vsp.spr-journal.ru:80/jour/article/view/1402
spellingShingle E.I. Alexeeva
E.L. Semikina
T.M. Bzarova
S.I. Valieva
R.V. Denisova
A.O. Lisitsin
E.Yu. Gudkova
S.S. Akulova
E.A. Kopyl'tsova
EXPERIENCE OF CLINICAL USE OF RITUXIMAB IN PATIENT WITH SYSTEMIC JUVENILE ARTHRITIS (A CASE REPORT)
Вопросы современной педиатрии
title EXPERIENCE OF CLINICAL USE OF RITUXIMAB IN PATIENT WITH SYSTEMIC JUVENILE ARTHRITIS (A CASE REPORT)
title_full EXPERIENCE OF CLINICAL USE OF RITUXIMAB IN PATIENT WITH SYSTEMIC JUVENILE ARTHRITIS (A CASE REPORT)
title_fullStr EXPERIENCE OF CLINICAL USE OF RITUXIMAB IN PATIENT WITH SYSTEMIC JUVENILE ARTHRITIS (A CASE REPORT)
title_full_unstemmed EXPERIENCE OF CLINICAL USE OF RITUXIMAB IN PATIENT WITH SYSTEMIC JUVENILE ARTHRITIS (A CASE REPORT)
title_short EXPERIENCE OF CLINICAL USE OF RITUXIMAB IN PATIENT WITH SYSTEMIC JUVENILE ARTHRITIS (A CASE REPORT)
title_sort experience of clinical use of rituximab in patient with systemic juvenile arthritis a case report
url http://vsp.spr-journal.ru:80/jour/article/view/1402
work_keys_str_mv AT eialexeeva experienceofclinicaluseofrituximabinpatientwithsystemicjuvenilearthritisacasereport
AT elsemikina experienceofclinicaluseofrituximabinpatientwithsystemicjuvenilearthritisacasereport
AT tmbzarova experienceofclinicaluseofrituximabinpatientwithsystemicjuvenilearthritisacasereport
AT sivalieva experienceofclinicaluseofrituximabinpatientwithsystemicjuvenilearthritisacasereport
AT rvdenisova experienceofclinicaluseofrituximabinpatientwithsystemicjuvenilearthritisacasereport
AT aolisitsin experienceofclinicaluseofrituximabinpatientwithsystemicjuvenilearthritisacasereport
AT eyugudkova experienceofclinicaluseofrituximabinpatientwithsystemicjuvenilearthritisacasereport
AT ssakulova experienceofclinicaluseofrituximabinpatientwithsystemicjuvenilearthritisacasereport
AT eakopyltsova experienceofclinicaluseofrituximabinpatientwithsystemicjuvenilearthritisacasereport